Steven Andrew Johnson Insider Trading
Get free email notifications about insider trading for Steven Andrew Johnson.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Steven Andrew Johnson. Steven Andrew Johnson is a VP, Preclinical Development in RespireRx Pharmaceuticals Inc. ($RSPI).
Address: 15241 BARRANCA PARKWAY IRVINE 92618 CA
Companies in which Steven Andrew Johnson is an Insider
RespireRx Pharmaceuticals Inc.
Trading Symbol: RSPIIndustry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Steven Andrew Johnson: VP, Preclinical Development
Holdings: 30,762 shares
Current Value: $119,972
Latest Transaction: Aug 24 2009
$RSPI Market Capitalization: $7.87M
$RSPI Previous Close: $3.90
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Latest Insider Trading Transactions of Steven Andrew Johnson
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Aug 24 2009 | RSPI | RespireRx Pharmace ... | Johnson Steven Andrew | VP, Preclinical Dev ... | Option Exercise | A | 0.20 | 262,000 | 52,400 | 262,000 | |
Dec 16 2008 | RSPI | RespireRx Pharmace ... | Johnson Steven Andrew | VP, Preclinical Dev ... | Option Exercise | M | 0.38 | 8,750 | 3,281 | 0 | |
Dec 16 2008 | RSPI | RespireRx Pharmace ... | Johnson Steven Andrew | VP, Preclinical Dev ... | Buy | M | 0.38 | 8,750 | 3,281 | 30,762 | 22 K to 30.8 K (+39.75 %) |
Jun 02 2008 | RSPI | RespireRx Pharmace ... | Johnson Steven Andrew | VP, Preclinical Dev ... | Grant | A | 0.78 | 11,012 | 8,589 | 22,012 | 11 K to 22 K (+100.11 %) |
Jan 22 2008 | RSPI | RespireRx Pharmace ... | Johnson Steven Andrew | VP, Preclinical Dev ... | Option Exercise | A | 0.54 | 100,000 | 54,000 | 100,000 |